MeSH term
Frequency | Condition_Probility | Animals | 15 | 0.0 |
Humans | 24 | 0.0 |
Base Sequence | 9 | 0.0 |
Blotting, Western | 5 | 0.0 |
Precipitin Tests | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 7 | 0.0 |
Tumor Cells, Cultured | 11 | 0.0 |
Rabbits | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Sequence Homology, Amino Acid | 9 | 0.0 |
Substrate Specificity | 6 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 22 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Up-Regulation | 2 | 0.0 |
Cells, Cultured | 5 | 0.0 |
Female | 6 | 0.0 |
Mice | 7 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 5 | 0.0 |
Amino Acid Sequence | 15 | 0.0 |
*Mitosis | 5 | 4.0 |
Molecular Sequence Data | 15 | 0.0 |
Proteasome Endopeptidase Complex | 2 | 0.0 |
Protein-Serine-Threonine Kinases/chemistry/*metabolism | 2 | 5.0 |
Alternative Splicing | 2 | 0.0 |
Cell Line | 7 | 0.0 |
Centrosome/*enzymology | 3 | 42.0 |
DNA, Complementary/genetics | 3 | 0.0 |
Dimerization | 2 | 0.0 |
Exons | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Hela Cells | 5 | 0.0 |
Introns | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Cell Cycle/*physiology | 2 | 0.0 |
Nocodazole/pharmacology | 2 | 1.0 |
Phosphoprotein Phosphatase/*metabolism | 3 | 3.0 |
Phosphorylation | 8 | 0.0 |
Protein-Serine-Threonine Kinases/genetics/*metabolism | 2 | 0.0 |
Transfection | 4 | 0.0 |
Genotype | 2 | 0.0 |
Mutagenesis | 2 | 0.0 |
Mutation | 5 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Cloning, Molecular | 7 | 0.0 |
DNA, Complementary | 3 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Catalytic Domain | 3 | 1.0 |
Male | 4 | 0.0 |
*Cell Cycle Proteins | 6 | 0.0 |
Comparative Study | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
*Xenopus Proteins | 3 | 0.0 |
Cell Line, Tumor | 3 | 0.0 |
Glutathione Transferase/metabolism | 3 | 0.0 |
Green Fluorescent Proteins | 2 | 0.0 |
Luminescent Proteins/metabolism | 2 | 0.0 |
Microscopy, Fluorescence | 4 | 0.0 |
Protein Binding | 5 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Cell Cycle | 4 | 0.0 |
Centrosome/*metabolism | 3 | 15.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Phylogeny | 2 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Time Factors | 2 | 0.0 |
